ArticleAsian Pacific journal of cancer prevention : APJCP2025
Evaluation of the Association between LMTK3 Gene Polymorphism and Breast Cancer Risk in the Indian Population.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this work was to elucidate the association of rs8108419 polymorphism in breast cancer patients in the Indian population.
methodsThis was a pilot study involving sixty-four patients with confirmed breast cancer recruited from Mahatma Gandhi Cancer Hospital and Research Institute, Visakhapatnam and twenty-six healthy individuals were the volunteer blood donors from GITAM (Deemed to be University), Visakhapatnam, with no records of breast cancer history or familial lineage of breast cancer. Blood collected from the above individuals was used to extract genomic DNA, and the PCR-RFLP was performed to analyse all the samples.
resultThere was no notable correlation between the genotypes of rs8108419 polymorphism and clinical characteristics like patient age, tumor stage and grade, tumor type, tumor size and distant metastasis. No correlation was observed between different subtypes of breast cancer and rs8108419 genotypes. The GG and GA genotypic frequencies were 90.6 and 9.3% in tumor cases and 92.3 and 8.3% in healthy controls, respectively. The LMTK3 genotype GA was linked with a greater risk for the development of breast cancer (Odds ratio: 1.24; 95% confidence interval: 0.63-14.6; P>0.05) than the GG genotype (Odds ratio: 0.80; 95% confidence interval: 0.15-4.27; P>0.05).
conclusionOverall, rs8108419 polymorphism was not associated with any clinicopathological factors in the above patients. However, the LMTK3 GA genotype was correlated with an increased incidence of breast cancer development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.